Press releases

All press releases published by Fagron are available on this page.

Investors Press releases

Fagron convenes Ordinary and Extraordinary General Meeting on 11 May 2026

Fagron reports solid first-quarter revenue of €263 million, reflecting 10% topline growth

Fagron increases share capital through exercise subscription rights

Disclosure of a transparency notification from Aberdeen Group plc

Disclosure of a transparency notification from Mawer Investment Management Ltd

Fagron publishes its Annual Report 2025

Fagron completes acquisition of Vepakum

Disclosure of a transparency notification from AOC Pharma S.à r.l.

Fagron completes strategic acquisition of Pharmavit Europe, strengthening its leadership in high‑growth nutraceutical ingredients across EMEA

Fagron continues its outstanding performance in FY 2025 with 9.2% topline growth and 10.9% increase in REBITDA